Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer

G Giaccone; P Zatloukal; J Roubec; K Floor; J Musil; M Kuta; RJ Klaveren; S Chauddhary; A Gunther; S Shamsili

Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer

G Giaccone, P Zatloukal, J Roubec, K Floor, J Musil, M Kuta, RJ Klaveren, S Chauddhary, A Gunther, S Shamsili

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

202 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	4481-4486
Number of pages	6
Journal	Journal of Clinical Oncology
Volume	27
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{aa7d0b7a77474047a07be7024de7e1eb,

title = "Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer",

author = "G Giaccone and P Zatloukal and J Roubec and K Floor and J Musil and M Kuta and RJ Klaveren and S Chauddhary and A Gunther and S Shamsili",

year = "2009",

language = "Undefined/Unknown",

volume = "27",

pages = "4481--4486",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer

AU - Giaccone, G

AU - Zatloukal, P

AU - Roubec, J

AU - Floor, K

AU - Musil, J

AU - Kuta, M

AU - Klaveren, RJ

AU - Chauddhary, S

AU - Gunther, A

AU - Shamsili, S

PY - 2009

Y1 - 2009

M3 - Article

SN - 0732-183X

VL - 27

SP - 4481

EP - 4486

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -